Showing 10,421 - 10,440 results of 28,755 for search '(( 50 ((ng decrease) OR (((a decrease) OR (mean decrease)))) ) OR ( 5 ng decrease ))', query time: 1.04s Refine Results
  1. 10421
  2. 10422
  3. 10423
  4. 10424
  5. 10425
  6. 10426
  7. 10427

    DataSheet_1_Severe radiation-induced lymphopenia during postoperative radiotherapy or chemoradiotherapy has poor prognosis in patients with stage IIB-III after radical esophagectom... by Wenjie Ni (6472181)

    Published 2022
    “…</p>Materials and methods<p>Post hoc analysis was conducted on data from 116 patients with esophageal cancer from a randomized controlled trial comparing adjuvant therapy with surgery alone. …”
  8. 10428

    Image_2_Healthcare Workers in South Korea Maintain a SARS-CoV-2 Antibody Response Six Months After Receiving a Second Dose of the BNT162b2 mRNA Vaccine.jpeg by Jae Hong Choi (3339120)

    Published 2022
    “…Positive nAbs (inhibition rates ≥ 20%) were measured in 166/249 (66.7%) subjects at visit 2, 237/243 (97.5%) subjects at visit 3, and 150/237 (63.3%) subjects at visit 4. A S-IgG (≥50 AU/mL) positivity was detected in 246/249 (98.8%) subjects at visit 1, and all participants had positive S-IgG antibody levels at visits 3 and 4 after being fully vaccinated. …”
  9. 10429

    Image_1_Healthcare Workers in South Korea Maintain a SARS-CoV-2 Antibody Response Six Months After Receiving a Second Dose of the BNT162b2 mRNA Vaccine.jpg by Jae Hong Choi (3339120)

    Published 2022
    “…Positive nAbs (inhibition rates ≥ 20%) were measured in 166/249 (66.7%) subjects at visit 2, 237/243 (97.5%) subjects at visit 3, and 150/237 (63.3%) subjects at visit 4. A S-IgG (≥50 AU/mL) positivity was detected in 246/249 (98.8%) subjects at visit 1, and all participants had positive S-IgG antibody levels at visits 3 and 4 after being fully vaccinated. …”
  10. 10430

    Data_Sheet_4_Immune-Inflammatory Parameters in COVID-19 Cases: A Systematic Review and Meta-Analysis.DOC by Xudong Feng (1426792)

    Published 2020
    “…In addition, the WBC count>10 × 10<sup>9</sup>/L, lymphocyte count<1 × 10<sup>9</sup>/L, PCT>0.5 ng/mL, and CRP>10 mg/L were risk factors for disease progression in patients with COVID-19 (WBC count>10 × 10<sup>9</sup>/L: OR = 2.92, 95% CI: 1.96–4.35; lymphocyte count<1 × 10<sup>9</sup>/L: OR = 4.97, 95% CI: 3.53–6.99; PCT>0.5 ng/mL: OR = 6.33, 95% CI: 3.97–10.10; CRP>10 mg/L: OR = 3.51, 95% CI: 2.38–5.16). …”
  11. 10431

    Data_Sheet_1_Immune-Inflammatory Parameters in COVID-19 Cases: A Systematic Review and Meta-Analysis.DOC by Xudong Feng (1426792)

    Published 2020
    “…In addition, the WBC count>10 × 10<sup>9</sup>/L, lymphocyte count<1 × 10<sup>9</sup>/L, PCT>0.5 ng/mL, and CRP>10 mg/L were risk factors for disease progression in patients with COVID-19 (WBC count>10 × 10<sup>9</sup>/L: OR = 2.92, 95% CI: 1.96–4.35; lymphocyte count<1 × 10<sup>9</sup>/L: OR = 4.97, 95% CI: 3.53–6.99; PCT>0.5 ng/mL: OR = 6.33, 95% CI: 3.97–10.10; CRP>10 mg/L: OR = 3.51, 95% CI: 2.38–5.16). …”
  12. 10432

    Data_Sheet_3_Immune-Inflammatory Parameters in COVID-19 Cases: A Systematic Review and Meta-Analysis.DOCX by Xudong Feng (1426792)

    Published 2020
    “…In addition, the WBC count>10 × 10<sup>9</sup>/L, lymphocyte count<1 × 10<sup>9</sup>/L, PCT>0.5 ng/mL, and CRP>10 mg/L were risk factors for disease progression in patients with COVID-19 (WBC count>10 × 10<sup>9</sup>/L: OR = 2.92, 95% CI: 1.96–4.35; lymphocyte count<1 × 10<sup>9</sup>/L: OR = 4.97, 95% CI: 3.53–6.99; PCT>0.5 ng/mL: OR = 6.33, 95% CI: 3.97–10.10; CRP>10 mg/L: OR = 3.51, 95% CI: 2.38–5.16). …”
  13. 10433

    Data_Sheet_2_Immune-Inflammatory Parameters in COVID-19 Cases: A Systematic Review and Meta-Analysis.DOC by Xudong Feng (1426792)

    Published 2020
    “…In addition, the WBC count>10 × 10<sup>9</sup>/L, lymphocyte count<1 × 10<sup>9</sup>/L, PCT>0.5 ng/mL, and CRP>10 mg/L were risk factors for disease progression in patients with COVID-19 (WBC count>10 × 10<sup>9</sup>/L: OR = 2.92, 95% CI: 1.96–4.35; lymphocyte count<1 × 10<sup>9</sup>/L: OR = 4.97, 95% CI: 3.53–6.99; PCT>0.5 ng/mL: OR = 6.33, 95% CI: 3.97–10.10; CRP>10 mg/L: OR = 3.51, 95% CI: 2.38–5.16). …”
  14. 10434
  15. 10435
  16. 10436
  17. 10437

    Mucolytic Effectiveness of Tyloxapol in Chronic Obstructive Pulmonary Disease - A Double-Blind, Randomized Controlled Trial by Martin Koppitz (2838347)

    Published 2016
    “…Interestingly, there was a mean increase in all inflammatory cytokines (IL-1β, IL-6, and IL-8) during the saline treatment from day 1 to week 3, whereas during the Tyloxapol treatment, all cytokines decreased. …”
  18. 10438

    Macrophages Mediate a Switch between Canonical and Non-Canonical Wnt Pathways in Canine Mammary Tumors by Magdalena Król (468133)

    Published 2014
    “…These observations indicate that rather than being “corrupted” by cancer cells, TAMs constitutively secrete canonical Wnt inhibitors that decrease tumor proliferation and development, but as a side effect, they induce the non-canonical Wnt pathway, which leads to tumor metastasis.…”
  19. 10439

    Image_1_The application of artificial intelligence in diabetic retinopathy screening: a Saudi Arabian perspective.jpeg by Abdulaziz A. Barakat (17438514)

    Published 2023
    “…Introduction<p>Diabetic retinopathy (DR) is the leading cause of preventable blindness in Saudi Arabia. With a prevalence of up to 40% of patients with diabetes, DR constitutes a significant public health burden on the country. …”
  20. 10440

    Table 1_Effects of icariin as a feed additive on the reproductive function in bucks (Capra hircus).docx by Fang-e Zhao (20140809)

    Published 2024
    “…The goats received oral administration of ICA at doses of 0 (control) and 50 mg/kg body weight daily for a consecutive period of 80 days during the breeding season. …”